Skip to main content
Journal of Experimental & Clinical Cancer Research : CR logoLink to Journal of Experimental & Clinical Cancer Research : CR
. 2022 Feb 15;41:63. doi: 10.1186/s13046-022-02268-7

Retraction Note: Ethaselen synergizes with oxaliplatin in tumor growth inhibition by inducing ROS production and inhibiting TrxR1 activity in gastric cancer

Haiyong Zhang 1,2,#, Jing Wu 1,#, Jinqiu Yuan 3,#, Huafu Li 1,2, Yawei Zhang 1,2, Wang Wu 1,2, Wei Chen 4, Chunming Wang 1,2, Sijun Meng 1, Songyao Chen 1, Mingyu Huo 1,, Yulong He 1,2,, Changhua Zhang 1,2,
PMCID: PMC8845271  PMID: 35168643

Retraction Note: J Exp Clin Cancer Res 40, 260 (2021)

https://doi.org/10.1186/s13046-021-02052-z

This article was published in error and has been removed.

All authors agree to this retraction.

Footnotes

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Haiyong Zhang, Jing Wu and Jinqiu Yuan contributed equally to this work.

Contributor Information

Mingyu Huo, Email: mingyu9318@163.com.

Yulong He, Email: heyulong@mail.sysu.edu.cn.

Changhua Zhang, Email: zhchangh@mail.sysu.edu.cn.


Articles from Journal of Experimental & Clinical Cancer Research : CR are provided here courtesy of BMC

RESOURCES